Correction: Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment Taketo EzakiToshihide TanakaHikaru Sasaki Correction Open access 07 May 2024
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment Taketo EzakiToshihide TanakaHikaru Sasaki Original Article Open access 15 April 2024 Pages: 61 - 72
Intratumoral heterogeneity of CDKN2A deletions in IDH-mutant astrocytoma Kenta MasuiHiromi OnizukaTakashi Komori Letter to the Editor 10 April 2024 Pages: 92 - 95
Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature Manabu NatsumedaSatoshi ShibumaMakoto Oishi Rapid Short communication 10 April 2024 Pages: 85 - 91
Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis Takahiro TsuchiyaMasako IkemuraNobuhito Saito Original Article Open access 05 April 2024 Pages: 73 - 79
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy Hikaru SasakiYohei KitamuraKazunari Yoshida Review Article 02 April 2024 Pages: 43 - 49
Development of a rapid and comprehensive genomic profiling test supporting diagnosis and research for gliomas Takuma NakashimaRyo YamamotoHiromichi Suzuki Original Article 08 February 2024 Pages: 50 - 60
Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment Fumi HiguchiTakeo UzukaKeisuke Ueki Case Report 31 January 2024 Pages: 80 - 84
Correction: Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next Takashi Komori Correction 25 January 2024 Pages: 96 - 96
Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation Satoshi NakataYasuhito AraiSumihito Nobusawa Letter to the Editor 22 December 2023 Pages: 35 - 39
Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next Takashi Komori Editorial 19 December 2023 Pages: 1 - 3
A rare case of primary central nervous system histiocytic sarcoma harboring a novel ARHGAP45::BRAF fusion: a case report and literature review Luyi ZhangGang ZhangHangyu Shi Case Report 15 December 2023 Pages: 18 - 29
FISH analysis reveals CDKN2A and IFNA14 co-deletion is heterogeneous and is a prominent feature of glioblastoma Sofian Al ShboulShelagh BoylePaul M. Brennan Original Article 14 December 2023 Pages: 4 - 17
Primary papillary epithelial tumor of the sella: a case report of an emerging tumor type S. RimaShilpa RaoRajneesh Kacchara Case Report 13 December 2023 Pages: 30 - 34
Touch imprint cytology is useful for the intraoperative pathological diagnosis of PitNETs’ surgical margins Noriaki TanabeNaoko InoshitaShozo Yamada Original Article Open access 06 October 2023 Pages: 215 - 221
Intraventricular central neurocytoma molecularly defined as extraventricular neurocytoma: a case representing the discrepancy between clinicopathological and molecular classifications Daisuke SatoHirokazu TakamiNobuhito Saito Case Report Open access 11 September 2023 Pages: 230 - 234
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype: case series of a new entity Katja BenderJohannes KahnDavid Kaul Original Article Open access 10 August 2023 Pages: 204 - 214
Integrated analysis of multiple methods reveals characteristics of the immune microenvironment in medulloblastoma Kaiyu FanYifan WeiJian Gong Original Article 09 August 2023 Pages: 191 - 203
Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis—a case report Natsuki OgasawaraShinji YamashitaHideo Takeshima Case Report 29 July 2023 Pages: 222 - 229
A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment Naohito HashimotoTomonari SuzukiAtsushi Sasaki Original Article Open access 16 June 2023 Pages: 163 - 175
α-SMA positive vascular mural cells suppress cyst formation in hemangioblastoma Maki SakaguchiRiho NakajimaMitsutoshi Nakada Original Article 05 June 2023 Pages: 176 - 184
IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis Satoshi NakasuShoichi DeguchiYoko Nakasu Review Article 22 May 2023 Pages: 143 - 157
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors Naoki ShinojimaKazutaka OzonoAkitake Mukasa Case Report Open access 22 April 2023 Pages: 185 - 190
Immunohistochemical and ultrastructural review of six cases previously diagnosed as null cell PitNETs Naoko InoshitaToyoki YoshimotoShozo Yamada Original Article 18 April 2023 Pages: 158 - 162
Spatial metabolic heterogeneity of oligodendrogliomas at single-cell resolution Sai BatchuMichael Joseph DiazBrandon Lucke-Wold Original Article 11 April 2023 Pages: 101 - 108
Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas Yoshihiro OtaniKaishi SatomiIsao Date Review Article 01 April 2023 Pages: 56 - 65
Impact of tumor markers on diagnosis, treatment and prognosis in CNS germ cell tumors: correlations with clinical practice and histopathology Hirokazu TakamiChristopher S. GraffeoKoichi Ichimura Original Article Open access 30 March 2023 Pages: 124 - 132
Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas Tomohide NishikawaFumiharu OhkaRyuta Saito Original Article 29 March 2023 Pages: 85 - 92
Clinical characteristics and radiological features of glioblastoma, IDH-wildtype, grade 4 with histologically lower-grade gliomas Kazuya MotomuraYuji KibeRyuta Saito Review Article 29 March 2023 Pages: 48 - 55
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence Ryota TamuraAkio IwanamiHikaru Sasaki Original Article 09 March 2023 Pages: 109 - 123
High-grade neuroepithelial tumor with EP300::BCOR fusion and negative BCOR immunohistochemical expression: a case report Hirokazu SuginoKaishi SatomiAkihiko Yoshida Case Report 22 February 2023 Pages: 133 - 141
Liquid biomarkers in glioma Sho TamaiToshiya IchinoseMitsutoshi Nakada Review Article 17 February 2023 Pages: 66 - 77
Utility of real-time polymerase chain reaction for the assessment of CDKN2A homozygous deletion in adult-type IDH-mutant astrocytoma Yuzaburo ShimizuMario SuzukiAkihide Kondo Original Article 14 February 2023 Pages: 93 - 100
Correction: Morphologically, genetically and spatially mixed astrocytoma and oligodendroglioma; chronological acquisition of 1p/19q codeletion and CDKN2A deletion: a case report Hirokazu TakamiAkitake MukasaNobuhito Saito Correction 19 January 2023 Pages: 142 - 142
Morphologically, genetically and spatially mixed astrocytoma and oligodendroglioma; chronological acquisition of 1p/19q codeletion and CDKN2A deletion: a case report Hirokazu TakamiAkitake MukasaNobuhito Saito Case Report 26 December 2022 Pages: 26 - 34
Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma Lei LouJiajun LiYuehong Li Original Article 22 December 2022 Pages: 15 - 25
Update of the 2021 WHO classification of tumors of the central nervous system: adult diffuse gliomas Takashi Komori Editorial 20 December 2022 Pages: 1 - 3
Three-dimensional visualization of human brain tumors using the CUBIC technique Yangyang XuQi HeJie Zhang Original Article 12 November 2022 Pages: 4 - 14
PBRM1 and BAP1: novel genetic mutations in malignant transformation of craniopharyngioma—a case report Mitsuru TamuraKiyotaka YokogamiHideo Takeshima Case Report 11 November 2022 Pages: 40 - 44
An extracranial CNS presentation of the emerging “intracranial” mesenchymal tumor, FET: CREB-fusion positive Arnault Tauziède-EspariatGaëlle PierronPascale Varlet Case Report 15 September 2022 Pages: 35 - 39
Clinical application of a highly sensitive digital PCR assay to detect a small fraction of IDH1 R132H-mutant alleles in diffuse gliomas Kaishi SatomiAkihiko YoshidaKoichi Ichimura Original Article 29 July 2022 Pages: 210 - 217
Whole-genome sequencing analysis of an atypical teratoid/rhabdoid tumor in a patient with Phelan–McDermid syndrome: a case report and systematic review Haruki YamashitaYoshiki ArakawaSusumu Miyamoto Case Report 24 June 2022 Pages: 232 - 239
Aggressive nonfunctioning pituitary neuroendocrine tumors Sérgio PortovedoLeonardo Vieira NetoLeandro Miranda-Alves Review Article 20 June 2022 Pages: 183 - 199
Loss of H3K27me3 in WHO grade 3 meningioma Andrea Daniela MaierChristian Beltoft BrøchnerTiit Mathiesen Original Article 09 June 2022 Pages: 200 - 209
A primary DICER1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL Kaiyun YangJustin WangJohn Provias Case Report 06 June 2022 Pages: 225 - 231
Revisiting the definition of glioma recurrence based on a phylogenetic investigation of primary and re-emerging tumor samples: a case report Toru UmeharaHideyuki AritaHaruhiko Kishima Case Report 06 June 2022 Pages: 218 - 224
A novel YAP1-MAML2 fusion in an adult supra-tentorial ependymoma, YAP1-fused Arnault Tauziède-EspariatAurore Siegfriedthe RENOCLIP-LOC Letter to the Editor 22 May 2022 Pages: 240 - 242
